#eczema Tech News.
1 story in the last 7 days
The latest eczema news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks eczema across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
DevQuartzabout 6 hours ago
AbbVie buys drug developer for nearly $11 billionAbbVie is acquiring an eczema and asthma drug developer for nearly $11 billion. The deal adds a late-stage pipeline asset to AbbVie's immunology portfolio. The acquisition targets a developer with treatments for inflammatory conditions.
Summaries by ByteBrief